Panacea Life Sciences Holdings, Inc. (PLSH): key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023): $2.4M
Net Income/Loss (FY2023): -$8.0M
Total Assets (FY2023): $18.0M
Total Equity (FY2023): -$8.3M
Cash Flows from Operating Activities (FY2023): -$1.5M

Source: Panacea Life Sciences Holdings, Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Panacea Life Sciences Holdings, Inc. (PLSH): key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023): $2.4M
Net Income/Loss (FY2023): -$8.0M
Total Assets (FY2023): $18.0M
Total Equity (FY2023): -$8.3M
Cash Flows from Operating Activities (FY2023): -$1.5M

Source: Panacea Life Sciences Holdings, Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.